Kliniske studier for Fedme i Montana
9 studier for Fedme søker deltakere på steder i Montana.
Byer i Montana
Offisiell studietekst (engelsk)
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
- Mercury Street Medical /ID# 282016, Butte
RekruttererFase 2
Alder 18 til 75 · Alle kjønn · Oppdatert 2. okt. 2026 · NCT07752979Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- Kalispell Regional Medical Center, Kalispell
RekruttererFase 3
Alder 18 til 99 · Alle kjønn · Oppdatert 16. sep. 2026 · NCT07037459A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Missoula
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 18 til 79 · Alle kjønn · Oppdatert 11. sep. 2026 · NCT07654374Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Missoula
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07284901Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
- Kailera Clinical Site, Missoula
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07284979Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
- Montana Medical Research, Missoula
RekruttererFase 3
Alder 18 til 99 · Alle kjønn · Oppdatert 27. aug. 2026 · NCT07575399A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
- Research Site, Butte
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 25. aug. 2026 · NCT07784725Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Butte
- ACCOMPLISH-1 Research Site, Missoula
RekruttererFase 3
Alder 18 til 79 · Alle kjønn · Oppdatert 10. aug. 2026 · NCT07654361A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Mercury Street Medical Group, PLLC, Butte
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 22. jul. 2026 · NCT07477704Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.